These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 31486030)
21. A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route. Wang Z; Yu B; Wang B; Yan J; Feng X; Wang Z; Wang L; Zhang H; Wu H; Wu J; Kong W; Yu X Oncotarget; 2016 Jul; 7(30):47287-47301. PubMed ID: 27323824 [TBL] [Abstract][Full Text] [Related]
24. A novel oncolytic adenovirus based on simian adenovirus serotype 24. Cheng T; Song Y; Zhang Y; Zhang C; Yin J; Chi Y; Zhou D Oncotarget; 2017 Apr; 8(16):26871-26885. PubMed ID: 28460470 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex. Kim J; Li Y; Kim SW; Lee DS; Yun CO Biomaterials; 2013 Jun; 34(19):4622-31. PubMed ID: 23541109 [TBL] [Abstract][Full Text] [Related]
26. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis. Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865 [TBL] [Abstract][Full Text] [Related]
27. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells. Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503 [TBL] [Abstract][Full Text] [Related]
28. A novel immunocompetent murine model for replicating oncolytic adenoviral therapy. Zhang L; Hedjran F; Larson C; Perez GL; Reid T Cancer Gene Ther; 2015 Jan; 22(1):17-22. PubMed ID: 25525035 [TBL] [Abstract][Full Text] [Related]
29. The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer. Lichtenegger E; Koll F; Haas H; Mantwill K; Janssen KP; Laschinger M; Gschwend J; Steiger K; Black PC; Moskalev I; Nawroth R; Holm PS Hum Gene Ther; 2019 Jan; 30(1):44-56. PubMed ID: 29916265 [TBL] [Abstract][Full Text] [Related]
30. Cancer gene therapy with oncolytic adenoviruses. Guse K; Hemminki A J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073 [TBL] [Abstract][Full Text] [Related]
31. Association of oncolytic adenoviruses with chemotherapies: an overview and future directions. Bressy C; Benihoud K Biochem Pharmacol; 2014 Jul; 90(2):97-106. PubMed ID: 24832861 [TBL] [Abstract][Full Text] [Related]
32. Oncolytic adenoviruses for the treatment of brain tumors. Gomez-Manzano C; Fueyo J Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384 [TBL] [Abstract][Full Text] [Related]
33. Retargeted adenoviruses for radiation-guided gene delivery. Kaliberov SA; Kaliberova LN; Yan H; Kapoor V; Hallahan DE Cancer Gene Ther; 2016 Sep; 23(9):303-14. PubMed ID: 27492853 [TBL] [Abstract][Full Text] [Related]
34. Oncolytic adenovirus based on serotype 3. Hemminki O; Bauerschmitz G; Hemmi S; Lavilla-Alonso S; Diaconu I; Guse K; Koski A; Desmond RA; Lappalainen M; Kanerva A; Cerullo V; Pesonen S; Hemminki A Cancer Gene Ther; 2011 Apr; 18(4):288-96. PubMed ID: 21183947 [TBL] [Abstract][Full Text] [Related]
35. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation. Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155 [TBL] [Abstract][Full Text] [Related]
36. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting. Jönsson F; Hagedorn C; Kreppel F J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881 [TBL] [Abstract][Full Text] [Related]
37. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. van Beusechem VW; Mastenbroek DC; van den Doel PB; Lamfers ML; Grill J; Würdinger T; Haisma HJ; Pinedo HM; Gerritsen WR Gene Ther; 2003 Nov; 10(23):1982-91. PubMed ID: 14528322 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy. Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660 [TBL] [Abstract][Full Text] [Related]
39. Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues. Koski A; Bramante S; Kipar A; Oksanen M; Juhila J; Vassilev L; Joensuu T; Kanerva A; Hemminki A Mol Ther; 2015 Oct; 23(10):1641-52. PubMed ID: 26156245 [TBL] [Abstract][Full Text] [Related]
40. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA. Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]